There trenbolone acetate powde are no clinical data on the possibility of use of the drug in pregnant women Dicynonum. Application Dicynonum during pregnancy is possible only if the expected benefit to the mother outweighs the potential risk to the fetus. There are no data regarding the allocation etamzilata breast milk. Therefore, when using the drug during lactation should decide the issue of termination of breastfeeding.
According to the World Health Organization (WHO), undesirable effects are classified according to their rate of development as follows: common (> 1/100, <1/10), uncommon (> 1/1000, <1/100), rarely (> 1 / 10,000, <1/1000) and very rare (<1/10000), including isolated reports. From the digestive system common: nausea, diarrhea, discomfort in the epigastric region. skin and subcutaneous tissue disorderscommon: skin rash, frequency unknown : flushing of the skin. From the nervous system common: headache frequency unknown: dizziness, paresthesia of the lower limbs. cardio-vascular system is very rare: thromboembolism, the frequency is not known: a pronounced reduction in blood pressure. From the blood system and the lymphatic system very rare: agranulocytosis, neutropenia, thrombocytopenia.On the part of the musculoskeletal system rarely: arthralgia. On the part of the immune system is very rare: allergic reactions. Other common: asthenia; very rarely . fever that arise in the treatment of side effects are usually reversible remove the drug. In the case of skin reactions or fever should stop treatment and inform your doctor as this may be a manifestation of a trenbolone acetate powder hypersensitivity reaction.
To date, no cases of overdose. If an overdose has occurred trenbolone results, it is necessary to start symptomatic therapy.
Interaction with other drugs
There is still no data on the interaction etamzilata with other drugs. The combination with aminocaproic acid, menadione sodium bisulfite.
Before treatment should exclude other causes of bleeding. The drug is not effective in patients with thrombocytopenia. In hemorrhagic complications associated with overdosage of anticoagulants, it is advisable to use specific antidotes. Use of the drug Dicynonum in patients with impaired performance of the blood coagulation system is possible, but it must be complemented by the introduction of drugs that trenbolone acetate powder eliminate the identified deficiency or defect of coagulation factors. Clinical trials of Dicynonum drug in patients with impaired liver and kidney functions are not carried out, so be careful when using etamzilata in this category of patients. Special precautions for the destruction bradley martyn cycle of unused medicinal product not required. online anabolic steroids pharmacy
anabolic steroids buy online